OREX Financial Facts

General and administrative: 12.26M
Loss from operations: -12.91M
See Full Income Statement

Total stockholders' equity: -20.89M
Total assets: -406.87M
See Full Balance Sheet

Orexigen Therapeutics (OREX) Earnings

  |   Expand Research on OREX
Next EPS Date 5/4/16 EPS Growth Rate -14.3%
Average EPS % Beat Rate -3.0% Revenue Growth Rate +78.4%
Average % Move 1-Wk after EPS -20.4% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/4/16 Q116 N/A-$0.16 N/A N/A$7.78M N/A N/A N/A
2/26/16 Q415 -$0.12-$0.08 -$0.04$4.9M$14.07M N/A Details
11/5/15 Q315 -$0.09-$0.16 +$0.07$10M$12.17M N/A Details
8/6/15 Q215 -$0.18-$0.17 -$0.01$5.2M$4.92M N/A Details
5/8/15 Q115 -$0.14-$0.14 $0.00$4.36M$7.28M N/A Details
2/25/15 Q414 $0.00$0.21 -$0.21$22.95M$49.65M N/A Details
11/10/14 Q314 $0.09-$0.13 +$0.22$30.9M$8.93M N/A Details
8/7/14 Q214 -$0.21-$0.21 $0.00$857K$1M N/A Details